
India · Pharmaceuticals startup
OneSource Specialty Pharma Limited is India’s first specialty pharmaceutical Contract Development and Manufacturing Organization (CDMO).
Funding reportedLast round: Venture (Round not Specified)
Follow OneSource and see its new rounds in your feed.Start following
OneSource Specialty Pharma Limited is India’s first specialty pharmaceutical Contract Development and Manufacturing Organization (CDMO).
Based in Bengaluru, the company offers comprehensive end-to-end services across biologics, drug-device combinations, complex injectables, and oral technologies, including soft gelatin capsules. OneSource was formed through the merger of three CDMO businesses and has over 30 years of operational experience in drug development and manufacturing. The company operates five globally regulatory-approved manufacturing sites and employs more than 1,300 professionals. OneSource serves global pharmaceutical and biotech companies, providing support from early-stage development through clinical trials to commercial supply. Its capabilities include producing biological drug products, soft gelatin capsules, and various injectable formats. OneSource is publicly listed on Indian stock exchanges and is focused on delivering customer-first solutions in the specialty pharma sector.
Funding, as reported
From OneSource's own website: 1 founder, 12 on the team.
What they build
Known for
medicalpharmaceuticalspharmaceutical manufacturing
Built with from their website
WP EngineOpenAIAIMicrosoft ExchangeSalesforceMySQLMicrosoft 365 Apps & ServicesAnthropic ClaudeGoDaddy DomainsWordpress
Microsoft Exchange OnlineMicrosoft 365OutlookPHPMicrosoft Email ProvidersGoDaddy Hosting
Add your raise, your deck and your story, and put OneSource in front of investors. Or tell us what we have wrong.